Natera Inc
About
Natera Inc (NASDAQ:NTRA) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Prospera™ Evidence in Heart and Lung Transplantation Featured Across 17 Presentations at ISHLT
Apr 13 2026
Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma
Apr 9 2026
Judge Awards 30% Ongoing Royalty to Natera for its MRD-Related Patents
Apr 7 2026
20 Abstracts at AACR Highlight Scale, Innovation and Clinical Impact of Natera’s Oncology Platform
Mar 31 2026
SignateraTM MRD Identifies Breast Cancer Patients Who Can Forgo Surgery
Financials
Revenue
$2.31 B
Market Cap
$29.48 B
EPS
-1.52